Masson C, Brégeon C, Ifrah N, Berton V, Housseau F, Rénier J C
Service de Rhumatologie, CHRU Angers.
Rev Rhum Mal Osteoartic. 1991 Jul-Sep;58(7):519-22.
The authors report the development of thrombocytopenia purpura in one patient with seropositive and erosive rheumatoid arthritis treated successfully for 11 months with D-penicillamine. Anti-platelet-bound antibodies were present, but also: anti-erythrocyte antibodies with hemolytic anemia (then defining Evans's syndrome): higher level of antinuclear antibodies; intermittent neutropenia. The responsibility of D-penicillamine is discussed, but thrombocytopenia purpura evolved for itself. Glucocorticoids alone, intravenous immunoglobulin, vincristine did not induced remission, which at least occurred under the association danazol-glucocorticoids, without toxicity, especially on the liver function.
作者报告了1例血清学阳性且有糜烂性类风湿关节炎的患者,用青霉胺成功治疗11个月后发生血小板减少性紫癜。存在抗血小板结合抗体,同时还有:伴有溶血性贫血的抗红细胞抗体(进而确诊为伊文氏综合征);抗核抗体水平升高;间歇性中性粒细胞减少。讨论了青霉胺的责任,但血小板减少性紫癜自行发展。单独使用糖皮质激素、静脉注射免疫球蛋白、长春新碱均未诱导缓解,而在达那唑-糖皮质激素联合使用时至少出现了缓解,且无毒性,尤其是对肝功能无毒性。